Also trades as: APLM (NASDAQ) · $vol 0M
APLMW NASDAQ
Apollomics, Inc.
1W: -10.3%
1M: -26.6%
3M: +26.5%
YTD: -20.4%
1Y: -59.6%
3Y: -80.6%
$0.01
-0.00 (-21.64%)
Weekly Expected Move ±17.0%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$155.2M
52W Range0.0063-0.23
Volume100
Avg Volume78,438
Beta2.07
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOHung-Wen Chen
Employees14
SectorHealthcare
IndustryBiotechnology
IPO Date2023-03-30
Websiteapollomicsinc.com
989 East Hillsdale Blvd
Foster City, CA 94404
US
Foster City, CA 94404
US
650 209 4055
About Apollomics, Inc.
Apollomics, Inc. functions as a clinical-phase biotechnology enterprise, concentrating its efforts on discovering and advancing novel cancer treatments to meet crucial, underserved patient requirements. The company was co-founded by Liang Yu Guo and Sanjeev Redkar in 2015, with its main operations based in Foster City, California.
Latest News
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
Apollomics Inc. Announces $2.0 Million Bridge Financing
Apollomics Inc. Announces $2.0 Million Bridge Financing
Apollomics Reports First Half 2025 Financial Results
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Chen Hung-Wen | 0 | — | 2026-03-19 | |
| Chen Hung-Wen | 0 | — | 2026-03-19 | |
| Chen Hung-Wen | 10,000 | — | 2026-03-19 | |
| CHEN HONG-JUNG | 0 | — | 2026-03-18 | |
| Jan Chen-Huan | 0 | — | 2026-03-18 |